ARTICLE | Company News
AstraZeneca, Clinigen Group sales and marketing update
February 16, 2015 8:00 AM UTC
Clinigen launched an international global access program for AstraZeneca’s CAZ-AVI. CAZ-AVI is a third-generation cephalosporin combined with avibactam, a broad-spectrum beta lactamase (LACTB) inhib...